Lidocaine: Balanced Equation

Lidocaine
Lidocaine is an acid-base titration, it is a titration of the salts of weak bases in

mixed non-aqueous media.
Lidocaine base can be determined by dissolving the sample in anhydrous acetic
acid R followed by back titration with 0.1 M perchloric acid. The end point is
determined potentiometrically because we have a really weak analyte but
crystal violet is also used as an indicator,but the method can be inaccurate in
very dilute or colored solutions.
Balanced equation
HClO4 + CH3COOH ⇌ CH3COOH2+ + ClO4−

C₁₄H₂₂N₂O + CH3COOH ⇌ C₁₄H₂₂N₂HO++ CH3COO−
CH3COOH2+ + CH3COO− ⇌ 2CH3COOH
Adding HClO4＋ C₁₄H₂₂N₂O ⇌ C₁₄H₂₂N₂HO+ ＋ ClO4−
1 mL of 0.1 M perchloric acid is equivalent to 23.43 mg of C₁₄H₂₂N₂O
Ratio of perchloric acid to lidocaine is 1:1

No. Of moles of perchloric acid= no. Of moles of lidocaine (M1V1=M2V2)
=1 ml* 0.1M
=0.1 mol which also equals to the number of moles of lidocaine
→0.1 mol*234.3
=23.43 mg which is equivalent to the mass written in the Bp
Actual Monograph of Lidocaine from British pharmacopea

(Ph Eur Monograph 0727)

C H N O 234.3 137-58-6

14 22 2

Action and use

Local anaesthetic; Class I antiarrhythmic.

Preparation

Lidocaine Ointment

Ph Eur

DEFINITION

2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide.

Content

99.0 per cent to 101.0 per cent (anhydrous substance).

CHARACTERS

Appearance

White or almost white, crystalline powder.

Solubility

Practically insoluble in water, very soluble in ethanol (96 per cent) and in methylene chloride.

IDENTIFICATION

First identification A.

Second identification B, C.

A. Infrared absorption spectrophotometry (2.2.24).

Comparison lidocaine CRS.

B. Melting point (2.2.14): 66 °C to 70 °C, determined without previous drying.

C. To about 5 mg add 0.5 mL of fuming nitric acid R. Evaporate to dryness on a water-
bath, cool, and dissolve the residue in 5 mL of acetone R. Add 0.2 mL of alcoholic potassium
hydroxide solution R. A green colour develops.

TESTS

Related substances

Liquid chromatography (2.2.29).

Test solution Dissolve 50.0 mg of the substance to be examined in the mobile phase and
dilute to 10.0 mL with the mobile phase.

Reference solution (a) Dissolve 50.0 mg of 2,6-dimethylaniline R (impurity A) in the mobile
phase and dilute to 100.0 mL with the mobile phase. Dilute 10.0 mL of this solution to 100.0
mL with the mobile phase.

Reference solution (b) Dissolve 5.0 mg of 2-chloro-N-(2,6-dimethylphenyl)acetamide R
(impurity H) in the mobile phase and dilute to 10.0 mL with the mobile phase.

Reference solution (c) Dilute 1.0 mL of the test solution to 10.0 mL with the mobile phase.

Reference solution (d) Mix 1.0 mL of reference solution (a), 1.0 mL of reference solution (b)
and 1.0 mL of reference solution (c), then dilute to 100.0 mL with the mobile phase.

Column:
— size: l = 0.15 m, 3.9 = ‫ ط‬mm;

— stationary phase: end-capped polar-embedded octadecylsilyl amorphous organosilica

polymer R (5 µm);

— temperature: 30 °C.

Mobile phase Mix 30 volumes of acetonitrile for chromatography R and 70 volumes of a
4.85 g/L solution of potassium dihydrogen phosphate R previously adjusted to pH 8.0 with
strong sodium hydroxide solution R.

Flow rate 1.0 mL/min.

Detection Spectrophotometer at 230 nm.

Injection 20 µL.

Run time 3.5 times the retention time of lidocaine.

Relative retention With reference to lidocaine (retention time = about 17 min): impurity H =
about 0.37; impurity A = about 0.40.

System suitability Reference solution (d):

— resolution: minimum 1.5 between the peaks due to impurities H and A.

Limits:
— impurity A: not more than the area of the corresponding peak in the chromatogram
obtained with reference solution (d) (0.01 per cent);

— unspecified impurities: for each impurity, not more than the area of the peak due to
lidocaine in the chromatogram obtained with reference solution (d) (0.10 per cent);

— total: not more than 5 times the area of the peak due to lidocaine in the chromatogram
obtained with reference solution (d) (0.5 per cent);

— disregard limit: 0.5 times the area of the peak due to lidocaine in the chromatogram
obtained with reference solution (d) (0.05 per cent).

Chlorides (2.4.4)

Maximum 35 ppm.

Dissolve 1.4 g in a mixture of 3 mL of dilute nitric acid R and 12 mL of water R.

Sulfates (2.4.13)

Maximum 0.1 per cent.

Dissolve 0.2 g in 5 mL of ethanol (96 per cent) R and dilute to 20 mL with distilled water R.

Water (2.5.12)

Maximum 1.0 per cent, determined on 1.00 g.

Sulfated ash (2.4.14)

Maximum 0.1 per cent, determined on 1.0 g.

ASSAY

To 0.200 g add 50 mL of anhydrous acetic acid R and stir until dissolution is complete.
Titrate with 0.1 M perchloric acid , determining the end-point potentiometrically (2.2.20).

1 mL of 0.1 M perchloric acid is equivalent to 23.43 mg of C H N O.

14 22 2

IMPURITIES

Specified impurities A.

Other detectable impurities (the following substances would, if present at a sufficient level,
be detected by one or other of the tests in the monograph. They are limited by the general
acceptance criterion for other/unspecified impurities and/or by the general monograph
Substances for pharmaceutical use (2034). It is therefore not necessary to identify these
impurities for demonstration of compliance. See also 5.10. Control of impurities in
substances for pharmaceutical use): B, C, D, E, F, G, H, I, J.

A. 2,6-dimethylaniline,

B. 2-(diethylazinoyl)-N-(2,6-dimethylphenyl)acetamide (lidocaine N-oxide),

C. N-(2,6-dimethylphenyl)acetamide,

D. N-(2,6-dimethylphenyl)-2-(ethylamino)acetamide,

E. 2,2′-iminobis(N-(2,6-dimethylphenyl)acetamide),

F. 2-(diethylamino)-N-(2,3-dimethylphenyl)acetamide,

G. N-(2,6-dimethylphenyl)-2-((1-methylethyl)amino) acetamide,

H. 2-chloro-N-(2,6-dimethylphenyl)acetamide,

I. 2-(diethylamino)-N-(2,4-dimethylphenyl)acetamide,

J. 2-(diethylamino)-N-(2,5-dimethylphenyl)acetamide.

Ph Eur

Lidocaine: Balanced Equation

Uploaded by

Copyright:

Available Formats

Lidocaine: Balanced Equation

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Lidocaine: Balanced Equation

Uploaded by

Copyright:

Available Formats

What is lidocaine used for?

What is lidocaine used for?

How is lidocaine determined quantitatively?

How is lidocaine determined quantitatively?

Lidocaine

Lidocaine is an acid-base titration, it is a titration of the salts of weak bases in

HClO4 + CH3COOH ⇌ CH3COOH2+ + ClO4−

Adding HClO4＋ C₁₄H₂₂N₂O ⇌ C₁₄H₂₂N₂HO+ ＋ ClO4−

1 mL of 0.1 M perchloric acid is equivalent to 23.43 mg of C₁₄H₂₂N₂O

Ratio of perchloric acid to lidocaine is 1:1

Actual Monograph of Lidocaine from British pharmacopea

Second identification B, C.

A. Infrared absorption spectrophotometry (2.2.24).

B. Melting point (2.2.14): 66 °C to 70 °C, determined without previous drying.

dilute to 10.0 mL with the mobile phase.

Reference solution (a) Dissolve 50.0 mg of 2,6-dimethylaniline R (impurity A) in the mobile

— size: l = 0.15 m, 3.9 = ‫ ط‬mm;

— stationary phase: end-capped polar-embedded octadecylsilyl amorphous organosilica

— temperature: 30 °C.

Mobile phase Mix 30 volumes of acetonitrile for chromatography R and 70 volumes of a

Flow rate 1.0 mL/min.

Detection Spectrophotometer at 230 nm.

Run time 3.5 times the retention time of lidocaine.

Relative retention With reference to lidocaine (retention time = about 17 min): impurity H =

about 0.37; impurity A = about 0.40.

System suitability Reference solution (d):

Dissolve 1.4 g in a mixture of 3 mL of dilute nitric acid R and 12 mL of water R.

1 mL of 0.1 M perchloric acid is equivalent to 23.43 mg of C H N O.

B. 2-(diethylazinoyl)-N-(2,6-dimethylphenyl)acetamide (lidocaine N-oxide),

G. N-(2,6-dimethylphenyl)-2-((1-methylethyl)amino) acetamide,

You might also like

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.